Thank you for your interest in participating in clinical research at Kadima Neuropsychiatry Institute.
The questions below help us determine whether you may be eligible for one of our active studies. They should take less than 3 minutes.
If your responses suggest a potential fit to one our trials, our recruiter will reach out to the pre-screening process. That conversation will cover what the study involves, what participation looks like day to day, and what risks and benefits you should know before deciding whether to move forward. Enrollment only happens with your informed consent.
Our trials are led by David Feifel, MD, PhD, a neuropsychiatrist and a UCSD Professor Emeritus who has been at the forefront of psychedelic and neuromodulation research for over two decades.
All studies are conducted at our La Jolla clinic and are regulated by the FDA.
Your privacy is our priority — your information will be securely stored on a HIPAA-compliant server and used only to assess eligibility and share research and treatment opportunities.